Çмú´ëȸ > ÇÁ·Î±×·¥
´ëÇÑ°£À̽Ŀ¬±¸ÇÐȸ 2018 Ãß°èÇмú´ëȸ ÇÁ·Î±×·¥

(0913 ver.)*ÇÁ·Î±×·¥Àº º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.

2018³â 10¿ù 12ÀÏ(±Ý) 
16:00~18:00  Poster Exhibition and discussion 1Ãþ ±×·£µåº¼·ë B
2018³â 10¿ù 13ÀÏ(Åä)
08:30~09:00 Registration ¡¡
09:00~09:05 Opening ´ëÇÑ°£À̽Ŀ¬±¸ÇÐȸ ȸÀå ±è¸í¼ö
Session 1: Free Paper Session                 1Ãþ ±×·£µåº¼·ë C
  ÁÂÀå: ±è¼øÀÏ (¿¬¼¼ÀÇ´ë), Ȳ½Å (¿ï»êÀÇ´ë)
09:05~09:15 Optimal Timing for Starting the Total Laparoscopic Living Donor Right Hepatectomy À̺¸¶÷ (¼­¿ïÀÇ´ë)¡¡
09:15~09:25 The experience of somatostatin to prevent small for size syndrome in a liver transplantation À±°æö (°í·ÁÀÇ´ë)¡¡
09:25~09:35 Favorable outcome of pathologic downstaging by locoregional treatment in liver transplantation ±è´ö±â (¿¬¼¼ÀÇ´ë)¡¡
09:35~09:45 Impact of body mass index ≥30 on pure laparoscopic donor right hepatectomy È«¼®±Õ (¼­¿ïÀÇ´ë)¡¡
09:45~09:55 Planned pregnancy and childbirth after living donor liver transplantation (case) È« ±Ù (ÀÌ´ëÀÇ´ë)¡¡
09:55~10:05 Large-for-size syndrome after deceased donor liver transplantation: A case report À±¿µÃ¶ (°¡Å縯ÀÇ´ë)¡¡
10:05~10:20 Coffee Break ¡¡
Session 2: MELD-based Allocation System: How are we doing?    1Ãþ ±×·£µåº¼·ë C
ÁÂÀå: ±è¸í¼ö(¿¬¼¼ÀÇ´ë), ³ª¾ç¿ø (¿ï»êÀÇ´ë)
10:20~10:40 Landscape of Liver Graft Allocation in MELD era. ÀÌÀç±Ù (¿¬¼¼ÀÇ´ë)
10:40~10:50 Q & A ¡¡
¡¡ Panel Discussion: How to improve our system?  
10:50~11:00 Group of patients that MELD does not reflect patient’s condition accurately - Hepatologist’s View °­¿ø¼® (¼º±Õ°üÀÇ´ë)
11:00~11:10 Group of patients that MELD does not reflect patient’s condition accurately - Surgeon’s View õÀç¹Î (°æºÏÀÇ´ë)
11:10~11:20 How to regulate alcohol-related liver disease? ¹ÚÁØ¿ë (¿¬¼¼ÀÇ´ë)
11:20~11:30 Blood type issues ±èµ¿½Ä (°í·ÁÀÇ´ë)
11:30~11:50 Futher discussion : Monitoring system & comittee for allocation system Discussion 
11:50~12:00 ÃÑȸ ¡¡
12:00~13:00 Lunch ÁöÇÏ1Ãþ NSK¡¡
Session 3: Unmet Needs in Health Insurance Coverage    1Ãþ ±×·£µåº¼·ë C
ÁÂÀå: Á¶Àç¿ø(¼º±Õ°üÀÇ´ë), ÃÖÀμ® (°Ç¾çÀÇ´ë) 
13:00~13:15 HBV antiviral agents ÃÖ¿øÇõ (°Ç´ëÀÇ´ë)
13:15~13:30 Antifungal prophylaxis ±èÁ¾ÈÆ (°í·ÁÀÇ´ë)
13:30~13:45 CMV prophylaxis  ±èÁ¾¸¸ (¼º±Õ°üÀÇ´ë)
13:45~14:00 Thymoglobulin for Steroid resistant ACR ÁÖµ¿Áø(¿¬¼¼ÀÇ´ë)
14:00~14:20 Streatigies for expansion of National Health Insurance Coverage Ȳ½Å (¿ï»êÀÇ´ë)
Session 4: Ongoing Dilemma : Acute Alcoholic Hepatitis 1Ãþ ±×·£µåº¼·ë C
ÁÂÀå: ÃÖµ¿¶ô (´ë±¸Ä«Å縯ÀÇ´ë), À̱¤¿õ(¼­¿ïÀÇ´ë) 
14:20~14:35 Differential Diagnosis and Treatment ¹ÚÁØ¿ë (¿¬¼¼ÀÇ´ë)
14:35~14:50 Role of Psychiatrist in evaluation of potential candidates À̱¤¹Î (¼­¿ï´ëº´¿ø)
14:50~15:05 Sobriety: How to implement in our system? À¯¿µ°æ (Ä«Å縯ÀÇ´ë)
15:05~15:20 Discussion ¡¡
15:20~15:40 Coffee Break ¡¡
Session 5: Technical Issue 1Ãþ ±×·£µåº¼·ë C
ÁÂÀå:  ¼­°æ¼® (¼­¿ïÀÇ´ë),  ±èÁÖ¼· (ÇѸ²ÀÇ´ë) 
15:40~16:00 Volumetry: Tips in various situations Á¤µ¿È¯ (¿ï»êÀÇ´ë)
16:00~16:20 Recipient hepatectomy: Tips for bloodless hepatectomy ±èºÀ¿Ï (¾ÆÁÖÀÇ´ë)
16:20~16:40 Optimal time arrangement for DDLT in various situations (Tips for minimizing cold ischemic time) ·ùÁ¦È£ (ºÎ»êÀÇ´ë)
16:40~17:00 Knack & Pitfalls of portal vein reconstruction in Pediatric or Lt. lobe graft LT À̳²ÁØ (¼­¿ïÀÇ´ë)
17:00~17:10 Closing ´ëÇÑ°£À̽Ŀ¬±¸ÇÐȸ ȸÀå ±è¸í¼ö